ABT
ABBOTT LABORATORIESD4615-min delayed · EOD close108.79 −1.52% downas of 2026-09-03mkt cap $189B
Pharmaceutical Preparations · SIC 2834 · CIK 0000001800
Income statement
| Metric | Value | Period | Source |
|---|---|---|---|
| Revenue | $45.1B | 2026-03-31 | 10-Q · 0001628280-26-028357 |
| Revenue (prior year) | $42.0B | 2024-12-31 | 10-K · 0001628280-25-007110 |
| Operating income | $7.7B | 2026-03-31 | 10-Q · 0001628280-26-028357 |
| Net income | $6.3B | 2026-03-31 | 10-Q · 0001628280-26-028357 |
Balance sheet
| Metric | Value | Period | Source |
|---|---|---|---|
| Total assets | $110B | 2026-03-31 | 10-Q · 0001628280-26-028357 |
| Current assets | $25.5B | 2026-03-31 | 10-Q · 0001628280-26-028357 |
| Current liabilities | $18.4B | 2026-03-31 | 10-Q · 0001628280-26-028357 |